Dr. Dustin Ray Portela, DO

Dr. Portela practices at Treasure Valley Dermatology & Skin Cancer Center in Boise, Idaho.

Dr. Portela's NPI, 1588002547, was assigned on June 11, 2013. Dr. Portela holds Idaho license O-1052.

Dr. Portela's primary practice is Treasure Valley Dermatology & Skin Cancer Center, at 999 N Curtis Rd, Boise, ID 83706 in Ada County. The practice phone is (208) 519-4333.

Dr. Portela's primary practice is Treasure Valley Dermatology & Skin Cancer Center in Boise, Idaho. Dr. Portela is also affiliated with St. Luke's Boise Medical Center. The medical group on file is Treasure Valley Dermatology & Skin Cancer Center. Dmand AI also links Dr. Portela to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Portela practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Portela's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Portela's licenses on file in 2 states: Idaho and Michigan.

CMS data shows 1,901 Medicare services from Dr. Portela across 11 procedure codes in 2024, for 417 Medicare patients. Medicare paid $76,340 for them. Every service was in an office.

CMS counts 417 Medicare patients who saw Dr. Portela in 2024. The largest group is 65 to 74, with 236 patients. 66% of them have high cholesterol, and 59% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Portela's median patient age at 70, with 45% women.

In 2024, Dr. Portela wrote 853 Medicare Part D claims for 290 patients. 84% of them were for generic drugs. CMS names the drug for 677 of them, across 23 drugs with 11 or more claims each, at $658,917 in total drug cost. In 2023, CMS named 523 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Portela for performance year 2024, reported as part of a group. Dr. Portela accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 261 procedures of skin biopsy by Dr. Portela, more than 89% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Portela, published from 2014 to 2024. The most frequent topics are Skin Neoplasms. Dr. Portela's most frequent co-authors are Jerry D. Brewer, MD, Aaron S. Farberg, MD and Meenal Kapoor Kheterpal, MD.

CMS Open Payments shows 638 general payments to Dr. Portela from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Dermavant Sciences, Inc. paid the most, $58,697.